Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Caspian Journal of Internal Medicine|February 6, 2023
Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis PopulationNegar Molazadeh, Mohammad Ali Sahraian, Mahsa GhajarzadehMultiple Sclerosis Journal - Experimental, Translational and Clinical|October 31, 2022
Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic reviewNegar Molazadeh, Gauruv Bose, Itay Lotan, et al.Multiple Sclerosis and Related Disorders|November 20, 2020
Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of IranNegar Molazadeh, Farnam Mohebi, Davar Altafi, et al.Multiple Sclerosis and Related Disorders|September 2, 2019
Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017)Sharareh Eskandarieh, Mohammad Ali Sahraiain, Negar Molazadeh, et al.Multiple Sclerosis and Related Disorders|November 10, 2023
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosisNegar Molazadeh, Tetsuya Akaishi, Gauruv Bose, et al.Journal of Neuroimmunology|September 21, 2021
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorderNegar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, et al.Iranian Journal of Neurology|November 22, 2019
Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorderSharareh Eskandarieh, Abdorreza Naser Moghadasi, Mohammad Ali Sahraiain, et al.International Journal of Preventive Medicine|September 19, 2022
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS)Mahsa Ghajarzadeh, Omid Mirmosayyeb, Negar Molazadeh, et al.Annals of Clinical and Translational Neurology|September 6, 2024
Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosisEvan Madill, Brian C Healy, Negar Molazadeh, et al.Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.Pageof 2